Angiogenesis inhibitors.

被引:13
|
作者
Tennant T.R. [1 ]
Rinker-Schaeffer C.W. [1 ]
Stadler W.M. [1 ]
机构
[1] Section of Hematology/Oncology, University of Chicago, 5841 South Maryland, Chicago, 60637, IL
关键词
Vascular Endothelial Growth Factor; Thalidomide; Angiogenesis Inhibitor; Clinical Trial Design; SU5416;
D O I
10.1007/s11912-000-0005-0
中图分类号
学科分类号
摘要
Angiogenesis inhibitors target the neovascular development that is hypothesized to underlie tumor growth. The inhibitors that are undergoing the clinical testing phase can be divided into five categories based on their target activity: 1) drugs that block matrix breakdown; 2) drugs that inhibit endothelial cells directly; 3) drugs that block angiogenesis activators; 4) drugs that inhibit endothelial cell integrins or survival signaling; and 5) drugs with a currently unknown mechanism of action. The properties of these drugs and some specific agents in each class are reviewed in this article. Because growth inhibition rather than tumor shrinkage is expected to be the clinical effect of angiogenesis inhibitors, some of the challenges and potential solutions for clinical trial design are also discussed.
引用
收藏
页码:11 / 16
页数:5
相关论文
共 50 条
  • [41] Synthesis of carbohydrate metalloprotease inhibitors.
    Hird, G
    Sheehy, M
    Khan, SI
    Beckham, E
    Grinstaff, MW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U127 - U127
  • [42] Peptides targeting caspase inhibitors.
    Tamm, I
    Trepel, M
    Cardo-Vila, M
    Sun, Y
    Welsh, K
    Cabezas, E
    Swatterthwait, A
    Arap, W
    Reed, JC
    Pasqualini, R
    BLOOD, 2003, 102 (11) : 137A - 137A
  • [43] Design of macrocyclic thrombin inhibitors.
    Greco, MN
    Powell, ET
    Hecker, R
    AndradeGordon, P
    Kauffman, JA
    Lewis, JM
    Ganesh, V
    Tulinsky, A
    Maryanoff, BE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 290 - MEDI
  • [44] Angiogenesis inhibitors
    Moslehi, Javid
    CHEMOTHERAPY, 2018, 63 (02) : 113 - 113
  • [45] Inhibitors of Angiogenesis
    Buening, H.
    Hacker, U. T.
    PROTEIN TARGETING COMPOUNDS: PREDICTION, SELECTION AND ACTIVITY OF SPECIFIC INHIBITORS, 2016, 917 : 261 - 285
  • [46] Inhibitors of angiogenesis
    Almendro V.
    Gascón P.
    Clinical and Translational Oncology, 2006, 8 (7) : 475 - 481
  • [47] Angiogenesis Inhibitors
    Das, Millie
    Wakelee, Heather
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (11) : S1801 - S1802
  • [48] INHIBITORS OF ANGIOGENESIS
    MOSES, MA
    LANGER, R
    BIO-TECHNOLOGY, 1991, 9 (07): : 630 - 634
  • [49] Angiogenesis inhibitors
    Powell, D
    Skotnicki, J
    Upeslacis, J
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 32, 1997, 32 : 161 - 170
  • [50] Cyanohydrins as nematode hatch inhibitors and weed germination inhibitors.
    Peterson, CJ
    Zhao, SH
    Tylka, GL
    Coats, JR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U50 - U50